ORASURE TECHNOLOGIES, INC Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ORASURE TECHNOLOGIES, INC (OSUR) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$13.77 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-09
- ORASURE TECHNOLOGIES, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$13.77M.
- ORASURE TECHNOLOGIES, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$3.33M.
- ORASURE TECHNOLOGIES, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$47.81M.
- ORASURE TECHNOLOGIES, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$36.82M.
- ORASURE TECHNOLOGIES, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$96.35M.
- ORASURE TECHNOLOGIES, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$8.06M.
- ORASURE TECHNOLOGIES, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$6.71M.
- ORASURE TECHNOLOGIES, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$7.98M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$13.77M 10-Q · filed 2018-05-09 | -$17.10M derived: sum of 2 quarters · filed 2018-05-09 | -$64.91M derived: sum of 3 quarters · filed 2018-05-09 | -$101.73M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | -$3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$51.14M derived: sum of 2 quarters · filed 2018-02-28 | -$87.96M derived: sum of 3 quarters · filed 2018-02-28 | -$96.35M 10-K · filed 2018-02-28 |
| 2017-09-30 | -$47.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$84.63M derived: sum of 2 quarters · filed 2017-11-09 | -$93.03M 10-Q · filed 2017-11-09 | -$97.58M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-06-30 | -$36.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$45.22M 10-Q · filed 2017-08-09 | -$49.77M derived: sum of 3 quarters · filed 2018-05-09 | -$50.55M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-03-31 | -$8.39M 10-Q · filed 2018-05-09 | -$12.95M derived: sum of 2 quarters · filed 2018-05-09 | -$13.73M derived: sum of 3 quarters · filed 2018-05-09 | -$14.86M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | -$4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$5.34M derived: sum of 2 quarters · filed 2018-02-28 | -$6.47M derived: sum of 3 quarters · filed 2018-02-28 | -$8.06M 10-K · filed 2018-02-28 |
| 2016-09-30 | -$783.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.92M derived: sum of 2 quarters · filed 2017-11-09 | -$3.51M 10-Q · filed 2017-11-09 | -$5.37M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$2.73M 10-Q · filed 2017-08-09 | -$4.59M derived: sum of 3 quarters · filed 2018-02-28 | -$5.33M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | -$1.59M 10-Q · filed 2017-05-09 | -$3.45M derived: sum of 2 quarters · filed 2018-02-28 | -$4.19M derived: sum of 3 quarters · filed 2018-02-28 | -$8.90M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$2.60M derived: sum of 2 quarters · filed 2018-02-28 | -$7.31M derived: sum of 3 quarters · filed 2018-02-28 | -$6.71M 10-K · filed 2018-02-28 |
| 2015-09-30 | -$740.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$5.45M derived: sum of 2 quarters · filed 2016-11-08 | -$4.85M 10-Q · filed 2016-11-08 | -$5.50M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$4.11M 10-Q · filed 2016-08-08 | -$4.76M derived: sum of 3 quarters · filed 2017-03-14 | -$5.67M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $602.00K 10-Q · filed 2016-05-10 | -$50.00K derived: sum of 2 quarters · filed 2017-03-14 | -$960.00K derived: sum of 3 quarters · filed 2017-03-14 | -$6.73M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | -$652.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$1.56M derived: sum of 2 quarters · filed 2017-03-14 | -$7.33M derived: sum of 3 quarters · filed 2017-03-14 | -$7.98M 10-K · filed 2017-03-14 |
| 2014-09-30 | -$910.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$6.68M derived: sum of 2 quarters · filed 2015-11-06 | -$7.33M 10-Q · filed 2015-11-06 | -$8.09M derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-06-30 | -$5.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$6.42M 10-Q · filed 2015-08-07 | -$7.18M derived: sum of 3 quarters · filed 2015-08-07 | -$7.79M derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-03-31 | -$647.00K 10-Q · filed 2015-05-08 | -$1.41M derived: sum of 2 quarters · filed 2015-05-08 | -$2.02M derived: sum of 3 quarters · filed 2015-05-08 | -$2.63M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | -$766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$1.37M derived: sum of 2 quarters · filed 2015-03-12 | -$1.98M derived: sum of 3 quarters · filed 2015-03-12 | -$2.46M 10-K · filed 2016-03-14 |
| 2013-09-30 | -$604.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$1.22M derived: sum of 2 quarters · filed 2014-11-07 | -$1.70M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | -$612.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | -$1.09M 10-Q · filed 2014-08-06 | ||
| 2013-03-31 | -$480.00K 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | -$2.02M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |